The first 10 years at Nanoform were about building a globally recognized technology platform and establishing partnerships with many of the world's leading pharmaceutical companies. We're scaling GMP clinical and commercial manufacturing, advancing products to market, expanding product out-licensing, and preparing for the launch of nanoenzalutamide. Our proprietary CESS® technology is increasingly being recognized not only for its scientific performance, but for its compelling economics.

In many applications, we believe CESS® offers the industry's most attractive combination of performance, scalability, sustainability, and cost, positioning Nanoform as a potential cost leader compared with conventional spray drying approaches. Proven success winning business in pharma, biotech, CDMO, CRO, drug delivery, or related life science markets. Pharma business development is a marathon, not a sprint.

Comfortable engaging with senior decision-makers and driving opportunities through complex sales cycles. Few companies are at this stage of growth. The commercial opportunity is expanding.

We offer a competitive compensation package and are open to creative structures that reward exceptional performance and value creation.

📌 Director Business Development (La Mancha)
🏢 Nanoform
📍 La Mancha